Ace Therapeutics offers you a full range of biomarker services for your anti-psychotic drug development needs. You don't even have to think about all the quality control, lengthy development steps, and data analysis. We can perform your experiments from a variety of biological samples: tissues, cell lines, and RNA. we will handle your samples from the beginning to the final quality control and data analysis in a very short time on our high throughput molecular platform. https://www.acetherapeutics.com/psychiatry/psychiatric-biomarker-testing-services.html

At Ace Therapeutics, we understand the unique challenges associated with developing novel candidate drugs for gastrointestinal diseases. We offer customized preclinical services to support your research and development needs, including the development and validation of disease models, in vitro pharmacodynamic platforms, and in vivo efficacy and safety studies. Web: https://www.acetherapeutics.com/gi-and-hepatology/preclinical-gastroenterology-cro-services.html

Due to changes in lifestyle and environmental pollution, cardiovascular disease is a leading cause of death in the world nowadays. Therefore, it is important to construct a reliable cardiovascular disease model in order to study its pathogenesis and preventive measures in depth.
Web: https://www.acetherapeutics.com/cardiovascular-diseases/cardiovascular-disease-models.html

At Ace Therapeutics, our irritable bowel syndrome (IBS) model customization service is tailored to meet the specific needs of researchers and pharmaceutical companies. We utilize advanced techniques to create representative models that reflect the diverse symptoms and pathophysiology of IBS. By offering flexible and professional solutions, we help our customers efficiently explore novel therapeutic targets and develop potential treatments.
Web: https://www.acetherapeutics.com/gi-and-hepatology/custom-irritable-bowel-syndrome-ibs-models.html

T2DM, which accounts for 90% of all diabetes, is a heterogeneous and progressive disease with a variety of causative and potentiating factors. The hyperglycemia of T2DM is often inadequately controlled, hence the need for a wider selection of glucose-lowering treatments. Ace Therapeutics can provide researchers engaged in drugs development of T2DM with more efficient function analysis and overall therapy services.
Our web: https://www.acetherapeutics.com/diabetes/t2dm-therapy-development-service.html